ISPC - iSpecimen Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.3400
-0.0400 (-2.90%)
At close: 04:00PM EDT
1.3400 0.00 (0.00%)
After hours: 07:51PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close1.3800
Open1.4000
Bid1.2600 x 3100
Ask1.3900 x 1100
Day's Range1.3000 - 1.4252
52 Week Range1.1700 - 3.2600
Volume39,903
Avg. Volume33,749
Market Cap12.099M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.2800
Earnings DateMay 04, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ISPC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on June 1, 2023

    LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group LLC (“Maxim”) and M-Vest, a division of Maxim, on Thursday, June 1, 2023. Ms. Curley will participate in a fireside chat with

  • GlobeNewswire

    iSpecimen Reports First Quarter 2023 Results

    Quarterly Revenue Increased 17% Year-Over-YearLEXINGTON, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three-month period ended March 31, 2023. “I am pleased to report that iSpecimen delivered strong revenue of approximately $3.0 million,

  • GlobeNewswire

    iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023

    LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Aegis Conference to be held virtually on May 2-4, 2023. Ms. Curley will present on Thursday, May 4, 2023, at 4:30 p.m. ET. To attend, please join here. For more

  • GlobeNewswire

    iSpecimen to Report First Quarter 2023 Results on May 4, 2023

    LEXINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the first quarter ended March 31, 2023 before the market opens on Thursday, May 4, 2023. The Company will host a conference call and audio webcast that morning at 8:30 a.m. Ea

  • Simply Wall St.

    Market Might Still Lack Some Conviction On iSpecimen Inc. (NASDAQ:ISPC) Even After 33% Share Price Boost

    iSpecimen Inc. ( NASDAQ:ISPC ) shares have had a really impressive month, gaining 33% after a shaky period beforehand...

  • Insider Monkey

    iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript

    iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript March 14, 2023 Operator: Good day, everyone and welcome to iSpecimen’s Full Year 2022 Conference Call. At this time, participants will be in a listen-only mode. A question-and-answer session will follow managements’ remarks. This conference call is being recorded. A replay of today’s call will be available […]

  • Thomson Reuters StreetEvents

    Q4 2022 iSpecimen Inc Earnings Call

    Q4 2022 iSpecimen Inc Earnings Call

  • GlobeNewswire

    iSpecimen Reports Full Year 2022 Results

    - Reported Record Quarterly Revenue of $3.2 Million, Up 28% Year-Over-Year -LEXINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended December 31, 2022. “At the beginning of the fourth quarter of 2022, I steppe

  • GlobeNewswire

    iSpecimen Named to Fast Company’s World’s Most Innovative Companies Annual List for 2023

    Award Highlights Businesses at the Forefront of Innovation That Are Transforming Industries and Shaping SocietyLEXINGTON, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers (“iSpecimen”), has been named to Fast Company’s annual list of the World’s Most Innovative Companies as part of the biotech category for 2023. Fast Company is

  • GlobeNewswire

    iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023

    LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022, before the markets open on Tuesday, March 14, 2023. The Company will host a conference call and audio webcast that mor

  • GlobeNewswire

    iSpecimen Expands Biospecimen Provider Network

    iSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and EuropeLEXINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that over the course of the second half of 2022, the Company added and onboarded seve

  • GlobeNewswire

    Maxim Group LLC to Host the Healthcare IT Virtual Conference on Wednesday, January 25th at 8:15 A.M. ET

    NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 25th at 8:15 A.M. ET Maxim Group LLC presents the Healthcare IT Virtual Conference. Participating companies focus on technology addressing rising health care costs, and scarcity of wo

  • GlobeNewswire

    iSpecimen Appoints Eric Langlois as Chief Revenue Officer

    Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company’s Former SVP of Sales and Business DevelopmentLEXINGTON, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that it appointed Eric Langlois as Chief Revenue Officer, effective immediately. Mr.

  • GlobeNewswire

    iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023

    LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Sequire Biotechnology Conference to be held virtually on Thursday, February 2, 2023. Ms. Curley will present at 5:00 p.m. ET. To attend, please register here. Fo

  • GlobeNewswire

    iSpecimen to Participate in Maxim’s Healthcare IT Virtual Conference on January 25, 2023

    LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group and M-Vest on Wednesday, January 25, 2023. Ms. Curley will present at 8:30 a.m. ET. To attend, please regi

  • GlobeNewswire

    iSpecimen Names Tracy Curley as Chief Executive Officer

    Previously Appointed Interim CEO in September 2022LEXINGTON, Mass., Jan. 10, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that its Board of Directors has appointed Tracy Curley, former Interim CEO, as CEO, effective immediately. “I am grateful to the Board and the entire team at iSpecimen for

  • GlobeNewswire

    iSpecimen Appoints Joseph J. Basile to Board of Directors

    Sought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimenLEXINGTON, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that the Company has appointed Joseph J. Basile to iSpecimen’s Board of Directors (the “Board”), as well

  • GlobeNewswire

    iSpecimen Reports Third Quarter 2022 Financial and Operating Results

    - Reported Revenue of $2.6 Million, Comprised Of A Record 88% Non-COVID Revenue -LEXINGTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three- and nine-month period ended September 30, 2022. “During the third quarter of 2022, iSpecime

  • Simply Wall St.

    Multiple insiders bought iSpecimen Inc. (NASDAQ:ISPC) stock earlier this year, a positive sign for shareholders

    Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

  • GlobeNewswire

    iSpecimen Launches New Open Feasibilities Dashboard on the iSpecimen Marketplace Platform to Enhance Biospecimen Fulfillment for Global Partner Network

    New Feature Provides Suppliers with Research Transparency to Optimize Fulfillment ProcessLEXINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that the Company has launched its new self-service Open Feasibilities Dashboard on iSpecimen Marketplace®, allowing supplier partners

  • GlobeNewswire

    iSpecimen to Report Third Quarter 2022 Results on November 8, 2022

    LEXINGTON, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the third quarter ended September 30, 2022, before the markets open on Tuesday, November 8, 2022. The Company will host a conference call and audio webcast that morning at 8:30

  • Newsfile

    iSpecimen to Participate in the ThinkEquity Conference on October 26, 2022

    Lexington, Massachusetts--(Newsfile Corp. - October 18, 2022) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, Interim CEO and CFO of iSpecimen, will present at the ThinkEquity Conference to be held at the Mandarin Oriental Hotel in New York City on October 26, 2022 at 4:30 p.m. ET. ...

  • GlobeNewswire

    iSpecimen Launches Marketplace Onsite Program to Optimize Biospecimen Procurement Process for Sample Providers

    New Program Designed to Support Provider Partners with Onsite CoordinatorLEXINGTON, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today launched its new Marketplace Onsite program to offer additional support to the Company’s biospecimen provider partners. The program embeds a coordinator at sel

  • GlobeNewswire

    iSpecimen Names Chief Financial Officer, Tracy Curley, Interim CEO

    Current President and CEO, Christopher Ianelli, to Leave CompanyLEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today the immediate appointment of Tracy Curley as interim CEO, replacing current Chief Executive Officer and President, Christopher Ianelli. In addition to servin

  • GlobeNewswire

    iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

    LEXINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on Septembe